{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:36:12Z","timestamp":1788478572245,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.parkreldis.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T20:30:17Z","timestamp":1507840217000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Non-motor symptoms and quality of life in dopa-responsive dystonia patients"],"prefix":"10.1016","volume":"45","author":[{"given":"E.R.","family":"Timmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-3878","authenticated-orcid":false,"given":"M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.I.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.T.","family":"Poll-The","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-4114","authenticated-orcid":false,"given":"T.","family":"Wassenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.J.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.parkreldis.2017.10.005_bib1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.10630","article-title":"Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)","volume":"54","author":"Segawa","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.50.4.1015","article-title":"Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia","volume":"50","author":"Furukawa","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.10.005_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.parkreldis.2015.07.003","article-title":"Non-motor symptoms in genetically defined dystonia: homogenous groups require systematic assessment","volume":"21","author":"Peall","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clineuro.2008.09.023","article-title":"Quality of life in patients with focal dystonia","volume":"111","author":"Pekmezovic","year":"2009","journal-title":"Clin.\u00a0Neurol. Neurosurg."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.npbr.2013.01.002","article-title":"Anxiety and depression in primary and secondary dystonia: a burden on health related quality of life","volume":"19","author":"Degirmenci","year":"2013","journal-title":"Neurol. Psychiatry Brain Res."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1194-236","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene","volume":"8","author":"Ichinose","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0079-6123(08)00929-1","article-title":"The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking","volume":"172","author":"Monti","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.10.005_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199210002-00003","article-title":"Serotonin and psychiatric disorders","volume":"7","author":"Lopez-Ibor","year":"1992","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neubiorev.2016.03.015","article-title":"Serotonergic perturbations in dystonia disorders-a systematic review","volume":"65","author":"Smit","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM199701163360306","article-title":"Melatonin in humans","volume":"336","author":"Brzezinski","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.2004.051664","article-title":"Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency","volume":"77","author":"Van Hove","year":"2006","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.10.005_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.10.005_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.58.5.749","article-title":"Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene","volume":"58","author":"Hahn","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/archneurol.2012.574","article-title":"Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs","volume":"69","author":"Tadic","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.parkreldis.2013.12.014","article-title":"Non-motor phenotype of dopa-responsive dystonia and quality of life assessment","volume":"20","author":"Bruggemann","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib16","first-page":"2155","article-title":"Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease","volume":"258","author":"Lopez-Laso","year":"2011","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.10.005_bib18","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib19","series-title":"M.I.N.I. PLUS - M.I.N.I. Internationaal Neuropsychiatrisch Interview","author":"Van Vliet","year":"2000"},{"key":"10.1016\/j.parkreldis.2017.10.005_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","article-title":"Reliability and validity of the Mini international neuropsychiatric interview for children and Adolescents (MINI-KID)","volume":"71","author":"Sheehan","year":"2010","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.10.005_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.parkreldis.2017.10.005_bib22","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.4088\/JCP.14019tx1c","article-title":"Effects of excessive daytime sleepiness and fatigue on overall health and cognitive function","volume":"76","author":"Roth","year":"2015","journal-title":"J.\u00a0Clin. Psychiatry"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017303620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017303620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T20:28:20Z","timestamp":1535315300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017303620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":22,"alternative-id":["S1353802017303620"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.005","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-motor symptoms and quality of life in dopa-responsive dystonia patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}